Chronic oxidative stress induces genomic amplification of the Ptprz1 gene in renal cell carcinoma cells [16], while doxorubicin has been shown to upregulate PTPRZ1 expression in triple-negative breast cancer cells [15]. The gene discussed is PTPRZ1; the disease is triple-negative breast carcinoma.